Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • Reporting Rate Calculator
  • Signal Detection
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Myocarditis
  • Guillain-Barré
  • Allergic Reactions
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. Meningococcal Conjugate (Menactra)
  4. Intensive care
Meningococcal Conjugate (Menactra)×Intensive care

Intensive care Reports for Meningococcal Conjugate (Menactra)

#217 most reported symptom for this vaccine

84
Reports
7
Deaths
75
Hospitalizations
8.33
Mortality Rate
%
89.3
Hosp. Rate
%

Intensive care and Meningococcal Conjugate (Menactra)

Intensive care has been reported 84 times in association with Meningococcal Conjugate (Menactra) vaccination in VAERS. This represents 0.2% of all 36,149 reports for this vaccine.

Among these reports, 7 mentioned death (8.33%) and 75 involved hospitalization (89.3%).

Intensive care is the #217 most frequently reported symptom for Meningococcal Conjugate (Menactra) out of 1843 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 84 reports of Intensive care after Meningococcal Conjugate (Menactra) vaccination may seem alarming, but context is critical.

The 8.33% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.

Important Context

•Association, not causation: These reports show Intensive care occurred after vaccination, not that the vaccine caused it.
•Background rates: Intensive care may occur naturally at baseline rates in the population, unrelated to vaccination.
•Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
•Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Similarly Ranked Symptoms

Injection site nodule86 reportsWhite blood cell count normal84 reportsAxillary pain84 reportsUnderdose84 reports

Quick Facts

Reports:84
Deaths:7
Hospitalizations:75
% of Vaccine:0.2%
Rank:#217 of 1843

Related Pages

Meningococcal Conjugate (Menactra) OverviewIntensive care (All Vaccines)Why Raw Numbers MisleadTop Symptoms Analysis

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.